Table of Contents Table of Contents
Previous Page  911 / 1082 Next Page
Information
Show Menu
Previous Page 911 / 1082 Next Page
Page Background

S895

ESTRO 36 2017

_______________________________________________________________________________________________

planning strategies were explored: 1) A new optimized

IMRT plan on each weekly MR image (WeeklyAdapt) 2) A

new optimized IMRT plan on week four MR image only

(OneAdapt) and 3) Calculating the plan from the planning

MR on each weekly MR image (NoAdapt). The PTV coverage

for all ViewRay MR-IGRT plans were such that 95% of the

PTV received 100% the prescription dose. The differences

between accumulated doses on planning MR for all three

ART strategies were evaluated using the dose-volume

constraints for targets and critical structures.

Results

For PTV70, PTV60 and PTV54, as compared to the D95

coverage on planning MR, the differences in D95

accumulated doses between three ART strategies were

<2%. The maximum dose to both cord and brainstem

between WeeklyAdapt and only OneAdapt were very

similar and <1% as compared to the planning MR

values. However, NoAdapt Dmax for brainstem and cord

were >27% and 25% than the original planning MR Dmax

values respectively. The mean left and right parotid dose

remained very similar both WeeklyAdapt and OneAdapt

strategies although there were up to 10.7% increase in the

mean dose to the parotids with NoAdapt strategy.

Conclusion

This study demonstrated that no significant differences in

accumulated doses were observed between weekly ART

and only one ART at week four during MR IGRT of H&N

cancer patients. Further studies are needed to evaluate

benefits of daily online ART during MR IGRT.

EP-1668 Dose calculation accuracy using CBCT images

for head and neck VMAT

M.A. Carrasco Herrera

1

, B. Quintana

2

, J.M. Nieto

2

, F.J.

Luis Simon

1

, C. Santa Marta Pastrana

3

1

Hospital Universitario Virgen del Rocio, Medical Physics

department, Sevilla, Spain

2

Hospital Universitario Virgen del Rocio, Radiation

Oncology department, Sevilla, Spain

3

Universidad Nacional de Educación a Distancia UNED,

2UDepartment of Mathematical Physics and of Fluids,

Madrid, Spain

Purpose or Objective

Assessment of the differences between CT and CBCT based

dose calculation for a volumetric modulated arc therapy

(VMAT) in head and neck radiotherapy treatment.

Material and Methods

CBCT images of an Alderson RANDO phantom with tissue-

equivalent material were acquired in a Varian`s On-Board

Imager OBI (v1.5) installed on a Varian DHX accelerator,

using its standard-dose head protocol (100 kV and 2.5 slice

thickness). On the other hand, planning CT images were

acquired in a Toshiba Aquilion LB using the same phantom

and with our own clinical head and neck protocol (120 kV

and 3 mm slice thickness). Different OAR (Body, spinal

cord, parotids, mandible, oropharynx, dermis, an inner

ring with 1 cm thickness and shoulder) and a PTV were

delimitated. Additionally, reference points were inserted

over all these structures. All defined structures and points

were registered with the CBCT images by means of the

Varian rigid registration software. Both the delimitation of

volumes and the design of the treatment plan have taken

into account the limited field of view of CBCT (length 16

cm, diameter 25 cm). A head and neck VMAT plan has been

calculated in Eclipse (v10) using both sets of images. For

CT images, we only used a standard calibration curve and

3 different calibration sets of curves for CBCT images, i.e.,

standard, measured with a CATPHAN 504 phantom and

measured with a CIRS 062M head phantom placed between

head and neck RANDO slices. Dose and HU were calculated

in all reference points as well as dose-volume-histograms

for the anatomical locations for both CT and CBCT. A

gamma analysis was used for HVD comparison.

Results

The mean HU differences are less than 50 UH and the

relative dose differences are less than 3% for all the

calibration curves (Table 1) on every reference point over

all the structures.

The gamma (2%, 2 mm) DHV analysis shows an excellent

agreement for almost all the structures (>95%) (Image1).

Ring and dermis have gamma >85% .The non-pass regions

correspond to very low dose regions. The worst gamma

(>50%) corresponds to the left parotid because it is a very

small structure (10 cc) into a high gradient dose zone.

Furthermore, there is a difference of 1.8% on its volume

as measured on the CBCT and the CT images, probably due

to interpolation errors. These results are similar for all the

calibration

curves analysed.